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There is ample evidence that, during surgical 
preparation, the loss of endothelial cells in the 
saphenous vein and impairment of their ability to 
produce prostacyclin and endothelium-derived r lax- 
ing factor promote platelet and leukocyte adhesion, 7 
and result in an early occlusion of 8-18% of grafts in 
the first month following surgeryJ The recently 
reported improvement in vein graft patency at 1 
month in man, with the topical application of prosta- 
cyclin analogues, 9 is likely to be due to its ability to 
counteract these effects by inhibiting platelet and 
leukocyte activation, aggregation and adhesion, and 
also improving raft flow, all of which have been well 
documentedJ "1°-12 Vein grafts that remain patent 
following this initial period experience a predictable 
and progressive intimal hyperplasia, long after the 
restoration of a morphologically intact endothelium 
and the termination of platelet and leucocyte adhe- 
sion. 13"14 This intimal thickening is caused by the 
proliferation and migration of vascular smooth muscle 
cells from the media, and results in late occlusions of 
saphenous vein grafts. In this stud~ we were not able 
to show any effect of Cicaprost on smooth muscle 
proliferation or intimal hyperplasia, we therefore 
conclude that it may not have any benefit in prevent- 
ing late saphenous vein graft failure. 
M.B. Izzat, T. Taylor, C.M. Holt and G.D. Angelini 
Bristol, U.K. 
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Femoral Osteochondroma 
Sir, 
I have read with interest he case reported by Fox et 
alJ about femoral artery occlusion secondary to a 
benign osteochondroma of the femur. Certainl~ inter- 
mittent claudication in young patients is extremely 
uncommon and unlikely to be atherosclerotic n
origin. Thorough investigation is warranted although 
I am not sure MRI added much information to the case 
described. 
Apart from arterial problems these patients may 
present with venous thrombosis--I have described a 
similar case of a 44-year-old man with a femoral 
metaphysis osteochondroma presenting with a spon- 
taneous DVT 3 years prior to the onset of occlusive 
arterial symptoms. 2 Plain radiography and colour 
flow Duplex were sufficient to diagnose the problem. 
Arteriography was necessary to determine the state of 
the distal vasculature - -  all 3 vessels were occluded 
secondary to microemboli. The case described by Fox 
et al. was fortunate in being diagnosed early, before 
distal microemboli caused further problems. 
In summar39 as stated by Fox et al. any young 
person presenting with symptoms and signs of arterial 
disease or spontaneous DVT warrants full investiga- 
tion. I would suggest plain radiograph~ colour flow 
Duplex and arteriography. 
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Pedal Aneurysms 
Sir, 
Recently, the European Journal of Vascular and Endovas- 
cular Surgery published a case report upon isolated 
aneurysm of pedal artery. 1There are few publications 
on this entity but in April 1993, I had to treat such a 
case. 
A 46-year-old male patient was referred by his 
general practitioner with a suspected synovial cyst of 
the dorsum of the left foot. Clinical examination 
reveals a pulsating, mass of about 2 cm diameter. The 
suspicion of pedal artery aneurysm was confirmed by 
ultrasonography which revealed partial thrombosis. 
No other aneurysm was found. Operation was per- 
formed under local anesthesia with loupe magnifica- 
tion. The aneurysm was resected and the tortuous 
pedal artery permitted sufficient mobilization to pro- 
ceed to direct end-to-end anastomosis with a 7.0 non- 
absorbable running suture. Histological analysis sug- 
gested an atherosclerotic aneurysm. Recovery was 
uneventful and more than 2 years later, the patient is 
asymptomatic and has palpable foot pulses. 
Most publications about peripheral aneurysms do 
not even mention this pathology. 2'3 This seems sur- 
prising as I doubt that this condition is really so 
infrequent. However, it seems a very benign condition 
and perhaps a number of such aneurysms have been 
operated on without being reported. It seems likely 
that a patient would present o a surgeon because of 
aesthetic considerations or local discomfort long 
before a hypothetic rupture of such an aneurysm 
would occur. Unless the pedal arch was embolised, 
ischaemia is also unlikely. I am thus convinced that 
pedal artery aneurysms, though quite infrequent, are 
not as exceptional as it might seem from the 
literature. 
M. Herrmann 
Onex, Switzerland 
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Carotid Patches 
Sir, 
The case report by White et al. 1 presents a fatal 
complication that is directly attributable to saphenous 
vein patch angioplasty, and yet the seven authors 
advocate continuing use of this technique. The risk of 
vein patch rupture has been acknowledged for many 
years, and although most reported cases resulted from 
the use of ankle saphenous vein, 2'3 rupture of a vein 
patch taken from thigh saphenous vein has been 
reported. 3 The relative paucity of reports of rupture in 
thigh vein patches may represent under reporting of 
an established complication. Although the incidence 
of vein patch rupture is low, it carries a substantial 
mortality and stroke risk, 3 and one cannot assume that 
thigh saphenous vein is completely safe. 
The logical action in the face of this evidence is to 
use an alternative patch material. PTFE patches may 
cause troublesome bleeding through the suture holes, 
which can prolong operation times, 4 but Dacron 
provides an acceptable alternative. Theoretically there 
is a greater isk of infection with Dacron, but there is 
no evidence to support his, or that rates of restenosis 
differ from saphenous vein patch angioplasty. Infec- 
tion has also been reported following saphenous vein 
patch closure. 5 This unit abandoned the use of 
saphenous vein patch angioplasty in 1989 following 
the initial reports of vein patch rupture. Both Dacron 
and PTFE patches were used from this time until May 
1992, when the use of PTFE was abandoned for the 
reasons tated above. Since then it has been our policy 
to routinely use knitted Dacron patches in all carotid 
endarterectomies, and we would advocate this as a 
safer patch material. 
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